Transfusion
Journal
Overview
publication venue for
-
Multidisciplinary management of a pregnancy complicated by Glanzmann thrombasthenia: A case report.
2023
-
Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
2021
-
Flat line in the blood bank: code H (hyperfibrinolysis)?
2020
-
Visual evidence of a hemolytic transfusion reaction identified by blood bank testing after emergency blood transfusion.
2019
-
The power of a trained eye: fatal transfusion-transmitted anaplasmosis and a case study in investigative work.
2019
-
Heparin-induced thrombocytopenia suggested by microscopic examination of a below-knee amputation.
2018
-
Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease.
2015
-
Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease.
2012
-
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.
2024
-
Analyzing and modeling massive transfusion strategies and the role of fibrinogen-How much is the patient actually receiving?
2024
-
Iatrogenic blood loss from phlebotomy during adult extracorporeal membrane oxygenation: A retrospective cohort study.
2024
-
Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
2023
-
Visualization dashboard for blood product inventory management..
63.
2023
-
Blood utilization in liver transplantation (BUILT): A multidisciplinary survey of transfusion practices..
63.
2022
-
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components..
62.
2022
-
Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality.
2022
-
Hemostatic efficacy of pathogen-reduced platelets in children undergoing cardiopulmonary bypass..
62.
2022
-
Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)..
61.
2021
-
Transfusion practices in a large cohort of hospitalized children..
61.
2021
-
A simplified CD34+ based preharvest prediction tool for HPC(A) collection..
61.
2021
-
Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services..
61.
2021
-
Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve..
61.
2020
-
Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children..
60.
2020
-
Rethinking the need for a platelet transfusion threshold of 50 × 109 /L for lumbar puncture in cancer patients..
60.
2020
-
Thawed solvent/detergent-treated plasma demonstrates comparable clinical efficacy to thawed plasma..
60.
2020
-
Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States..
60.
2020
-
Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?.
60 Suppl 3.
2020
-
Additive effects of blood donor smoking and gamma irradiation on outcome measures of red blood cell transfusion..
60.
2020
-
Increase in Google search interest for paid plasma donation in the United States during and after the great recession..
59.
2019
-
Pathogen reduced plasma products: a clinical practice scientific review from the AABB..
59.
2019
-
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee..
59.
2019
-
Red blood cells donated by smokers: A pilot investigation of recipient transfusion outcomes..
59.
2019
-
Influence of blood storage age on immune and coagulation parameters in critically ill transfused patients..
59.
2019
-
Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery..
59.
2019
-
Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro..
59.
2019
-
The impact of Daratumumab on transfusion service costs..
59.
2019
-
Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States..
59.
2018
-
Platelet transfusion practices in immune thrombocytopenia related hospitalizations..
59.
2018
-
Logistical and safety implications of temperature-based acceptance of returned red blood cell units..
58.
2018
-
Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors?.
58.
2018
-
Assessing our current practice: point prevalence studies in transfusion medicine..
58.
2018
-
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience..
58.
2017
-
Influence of cryoprecipitate, Factor XIII, and fibrinogen concentrate on hyperfibrinolysis..
57.
2017
-
Intrauterine transfusions for severe fetal anemia and hydrops due to de novo εγδβ-thalassemia..
57.
2017
-
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia..
56.
2016
-
Cryoprecipitate indications and patterns of use in the pediatric intensive care unit: inappropriate transfusions and lack of standardization..
56.
2016
-
The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and function..
56 Suppl 1.
2016
-
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation..
56.
2015
-
A novel bioreactor and culture method drives high yields of platelets from stem cells..
56.
2015
-
Can the interval between antibody identifications be increased for alloimmunized patients?.
56.
2015
-
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products..
56.
2015
-
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration..
55.
2015
-
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections..
55.
2015
-
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions..
55.
2015
-
A comparison of adverse reaction rates for PAS C versus plasma platelet units..
54.
2014
-
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States..
54.
2013
-
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)..
54.
2013
-
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia..
54.
2013
-
Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor..
54.
2013
-
Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications..
53.
2012
-
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center..
53.
2012
-
Cardiovascular disease risk assessment and prevention in blood donors..
52.
2012
-
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI..
52.
2011
-
Demographic differences in estimated blood donor eligibility prevalence in the United States..
52.
2011
-
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation..
51.
2011
-
Transfusion medicine illustrated. The role of plasmapheresis in the multimodal treatment of anti-Pr cold agglutinin disease..
50.
2010
-
Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform..
50.
2009
-
Extracellular DNA in cord blood plasma and applications in cord blood banking for sample identification..
49.
2009
-
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions..
48.
2008
-
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis..
46.
2006
-
Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities..
46.
2006
-
Removal of ABO-incompatible red cells from lymphocytapheresis and granulocytapheresis components before transfusion..
37.
1997
-
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients..
31.
1991
-
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura..
28.
1988
-
Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation?.
23.
1983
-
A prospective study of platelet-transfusion therapy administered to patients with acute leukemia..
22.
1982
-
Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease..
17.
1977
-
Glanzmann's thrombasthenia; assessment of the response to platelet transfusions..
15.
1975
-
Blood group studies of jungle Indians of the Mato Grosso..
2.
1962
-
Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic..
60.
2020
-
Babesia screening: the importance of reporting and calibration in cost-effectiveness models..
56.
2016
-
Universal WBC reduction and patient advocacy..
40.
2000
-
Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin..
26.
1986
-
Response to Wirtz et al: The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients.
2021
-
Historical ABO blood group discrepancy: a blessing in disguise to unravel a medical identity theft.
2017
-
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop.
2012
-
Conservation of O- red blood cells: a fresh look at a shared responsibility..
58.
2018
-
What do we know about intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia?.
56.
2016
-
Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss..
52.
2012
-
Identifying babies with neonatal alloimmune thrombocytopenia and the responsible antigens..
47.
2007
-
Transfusion management for children supported by extracorporeal membrane oxygenation.
2021
-
Assessment of platelet function utilizing viscoelastic testing.
2020
-
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.
2020
-
Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura.
2019
-
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).
2011
-
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.
2006
-
Thirty years of experience with solvent/detergent-treated plasma for transfusion medicine.
2024
-
Vitamin K antagonist reversal strategies: Systematic review and network meta-analysis from the AABB.
2022
-
The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing.
2020
-
The use of coagulation factor concentrates for perioperative bleeding management - a global perspective.
2020
-
Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials?
2019
-
Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee.
2018
-
Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines.
2014
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)